AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 19(4), 1970, pp. 677-679
Copyright © 1970 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leifer, E.
Right arrow Articles by Bourne, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leifer, E.
Right arrow Articles by Bourne, H.

Lassa Fever, a New Virus Disease of Man from West Africa

II. Report of a Laboratory-Acquired Infection Treated with Plasma from a Person Recently Recovered from the Disease

Edgar Leifer, David J. Gocke AND Henry Bourne
Department of Medicine, Columbia University College of Physicians and Surgeons, and The Presbyterian Hospital, New York, New York 10032

An investigator was infected with Lassa virus while working with tissue cultures and mice infected with the virus. Prodromal symptoms of illness were malaise, shivering sensations, and severe pain in the lower portion of both thighs. A severe, acute, systemic, febrile illness ensued; its prominent features were myositis, myocarditis, and thrombocytopenia. Lassa virus was isolated from throat washings, blood serum, and urine. Complement-fixing antibody against Lassa virus was detected on the 52nd day after onset of illness. Administration of 500 ml of plasma from a person recovered from infection with Lassa virus, on the 10th day of illness, seemingly resulted in aborting the course of the disease.

Accepted for publication January 20, 1970.




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
T. G. Kimman, E. Smit, and M. R. Klein
Evidence-Based Biosafety: a Review of the Principles and Effectiveness of Microbiological Containment Measures
Clin. Microbiol. Rev., July 1, 2008; 21(3): 403 - 425.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
R. A. Medina, K. Mirowsky-Garcia, J. Hutt, and B. Hjelle
Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model
J. Gen. Virol., February 1, 2007; 88(2): 493 - 505.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. Borio, T. Inglesby, C. J. Peters, A. L. Schmaljohn, J. M. Hughes, P. B. Jahrling, T. Ksiazek, K. M. Johnson, A. Meyerhoff, T. O'Toole, et al.
Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management
JAMA, May 8, 2002; 287(18): 2391 - 2405.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of the Royal Society for the Promotion of HealthHome page
R.T.D. Emond
Lassa Fever
The Journal of the Royal Society for the Promotion of Health, April 1, 1980; 100(2): 48 - 52.


Home page
 The Journal of the Royal Society for the Promotion of HealthHome page
N.S. Galbraith and J.R.H. Berrie
Public Health Aspects of Viral Haemorrhagic Fevers in Britain
The Journal of the Royal Society for the Promotion of Health, August 1, 1978; 98(4): 152 - 160.


Home page
 ScienceHome page
T. P. Monath, V. F. Newhouse, G. E. Kemp, H. W. Setzer, and A. Cacciapuoti
Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone
Science, July 19, 1974; 185(4147): 263 - 265.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American Society of Tropical Medicine and Hygiene.